Gain Therapeutics Appoints CEO Gene Mack As Interim CFO, Effective Oct. 1, Succeeding Principal Financial Officer Gianluca Fuggetta

Benzinga Newsdesk www.benzinga.com Neutral 92.7%

Neg 0% Neu 92.7% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1819411/000110465926111391/tm2626106d1_8k.htm

Comments

No comments yet. Be the first!